OPKO Health, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OPKO Health, Inc. stock issued during period, value, new issues for fiscal 2019 was $76.06M, a 17.77% decline from fiscal 2018.
- OPKO Health, Inc. stock issued during period, value, new issues for fiscal 2018 was $92.50M.
- OPKO Health, Inc. stock issued during period, value, new issues for fiscal 2012 was -$101.25M, a 196.59% decline from fiscal 2011.
- OPKO Health, Inc. stock issued during period, value, new issues for fiscal 2011 was $104.83M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2019-12-31 | $76.06M 10-K · filed 2022-03-01 | |
| 2018-12-31 | $92.50M 10-K · filed 2021-02-18 | |
| 2012-12-31 | -$101.25M 10-K · filed 2013-03-18 | |
| 2011-12-31 | $104.83M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |